Browse
Explore clinical trials and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
91022 trials found · Page 121 of 4552
-
Massive trial tests simple injection to stop blindness after cataract surgery
Prevention Not yet recruitingIntracameral injection of 0.1% moxifloxacin solution after cataract surgery to prevent endophthalmitis
Phase: PHASE2, PHASE3 • Sponsor: Jason Ahee, M.D. • Aim: Prevention
Last updated May 05, 2026 11:56 UTC
-
Virus therapy takes on childhood brain tumors: a new hope for recurrent cases?
Disease control Recruiting nowThis phase I trial tests the safety, side effects and best dose of AdV-HSV1-TK and AdV-Flt3L in combination with valacyclovir for the treatment of patients with primary cancerous (malignant) brain tumors that can be removed by surgery (resectable) and that have come back after a …
Phase: PHASE1 • Sponsor: University of Michigan Rogel Cancer Center • Aim: Disease control
Last updated May 06, 2026 16:15 UTC
-
AI could predict cancer return 20% better than current tests
Knowledge-focused Not yet recruitingCurrent decision tools (TNM, MRI/PET, CEA, and other serum markers, as well as single-marker genomics) are insufficiently predictive of responders, fail to detect early MRD in many cases, and rarely connect molecular biology to dynamic perioperative data. SAFE-AI will build and v…
Sponsor: Università Politecnica delle Marche • Aim: Knowledge-focused
Last updated Apr 26, 2026 20:01 UTC
-
Biomarker-Guided drug shows promise in preventing deadly transplant complication
Prevention Recruiting nowThis phase I trial studies how well biomarker-guided ruxolitinib works for the prevention of chronic graft versus host disease (GVHD) in patients that have undergone allogeneic hematopoietic cell transplant (HCT). Allogeneic HCT is the most effective therapy for patients with hig…
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Prevention
Last updated Apr 29, 2026 15:15 UTC
-
New drug cocktail aims to shrink esophageal tumors before surgery
Disease control Not yet recruitingIn the past few decades, surgery, radiotherapy, chemotherapy and other treatments were continuously improved, however, the mortality of esophageal squamous cell carcinoma patients was not significantly decreased. It is recommended that a treatment strategy be employed that integr…
Phase: PHASE2 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated May 04, 2026 16:22 UTC
-
New app aims to help native americans kick the smoking habit
Disease control Not yet recruitingThis clinical trial develops a chatbot smartphone application (app), QuitBot, and text messaging to help American Indians (AI) and Alaska Natives (AN) to quit smoking commercial tobacco (smoking cessation), and evaluates two remote smoking cessation programs to see how well they …
Phase: NA • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Apr 24, 2026 16:17 UTC
-
Diabetes drug shows promise against advanced prostate cancer in new trial
Disease control Not yet recruitingDapagliflozin is a well-established medication being marketed and used for treatment Type 2 diabetes mellitus (T2DM). In retrospective cohort studies done by our team, we found that metastatic prostate cancer patients who received Dapagliflozin together with standard anti-cancer …
Phase: PHASE2 • Sponsor: Yung NA • Aim: Disease control
Last updated May 01, 2026 15:59 UTC
-
Vulvar cancer patients may avoid invasive surgery with ultrasound monitoring
Disease control Not yet recruitingThis study is a phase III, open label, multicentre, three-group, randomised clinical trial. The primary aim of this study is to determine whether intensive groin ultrasound monitoring (1) is effective and safe to replace invasive groin lymph node dissection (LND) to manage vulvar…
Phase: PHASE3 • Sponsor: Queensland Centre for Gynaecological Cancer • Aim: Disease control
Last updated May 07, 2026 09:08 UTC
-
New study aims to stop obesity before it starts in High-Risk youth
Prevention Not yet recruitingThe investigators believe they key to effective prevention of obesity is early identification of individuals at high risk of excess weight gain and proactive implementation of a comprehensive approach including lifestyle-based coaching and preventive medical management targeting …
Phase: PHASE3 • Sponsor: University of Minnesota • Aim: Prevention
Last updated May 04, 2026 16:21 UTC
-
New CAR-T therapy made inside the body could cut costs for blood cancer patients
Disease control Not yet recruitingThe currently CAR-T cell therapy in clinical practice largely depends on the expansion of CAR-T cells in vivo. However, the in vitro preparation process of CAR-T cells is complex and costly. In vivo CAR-T cell therapy eliminates the need for ex vivo preparation, significantly red…
Phase: PHASE1 • Sponsor: Qi deng • Aim: Disease control
Last updated May 06, 2026 16:14 UTC
-
Sound waves and immunotherapy join forces against deadly brain tumor
Disease control Not yet recruitingNavigated Focused Ultrasound and Pembrolizumab in the Treatment of Recurrent WHO Grade 4 IDH-Wildtype Glioblastoma with Mismatch Repair Deficiency.
Phase: PHASE1 • Sponsor: Jennifer Leddon • Aim: Disease control
Last updated May 04, 2026 16:23 UTC
-
Vitamin d trial aims to protect pregnant women from Life-Threatening conditions
Prevention Not yet recruitingThe goal of this randomised controlled trial is to investigate if vitamin D supplementation among pregnant women in Uganda prevents adverse maternal and foetal outcomes, with special emphasis on preeclampsia. The main question it aims to answer is if Vitamin D supplementation, a…
Phase: PHASE4 • Sponsor: St Mary's Hospital, Lacor • Aim: Prevention
Last updated May 04, 2026 16:29 UTC
-
Poop pills could stop deadly bile duct infections
Disease control Not yet recruitingPatients with abnormalities of the biliary tract (the system that connects the liver to the small intestine and allows bile to flow) are prone to the development of strictures, dilations, or other problems that impede bile flow and promote the formation of gallstones. All of this…
Phase: PHASE2 • Sponsor: Puerta de Hierro University Hospital • Aim: Disease control
Last updated May 04, 2026 16:23 UTC
-
New drug combo aims to make liver tumors removable in colorectal cancer patients
Disease control Not yet recruitingThis study is a single-center, prospective, randomized, single-arm phase II clinical trial designed to evaluate the safety and efficacy of FULIRI chemotherapy regimen combined with targeted therapy (bevacizumab/cetuximab) as first-line conversion therapy for colorectal cancer wit…
Phase: PHASE2 • Sponsor: Zhongnan Hospital • Aim: Disease control
Last updated May 04, 2026 16:31 UTC
-
New drug cocktail aims to stop AML from coming back
Disease control Not yet recruitingStudy Objectives: To evaluate the Relapse-Free Survival (RFS) and 1-year RFS rate in patients with Acute Myeloid Leukemia (AML) receiving maintenance therapy with Chidamide combined with Venetoclax and Azacitidine. Study Design: Prospective, Multicenter, Interventional Cohort …
Phase: NA • Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Disease control
Last updated May 06, 2026 16:01 UTC
-
New app aims to stop Parkinson's drug side effects before they start
Prevention Not yet recruitingImpulse control disorders and related behaviors (ICDRBs) are characterized by pathological gambling, compulsive shopping or eating, and hypersexuality, but other related behaviors have been described, e.g. hobbyism, and punding. ICDRBs are frequent in Parkinson's Disease (PD), af…
Phase: NA • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Prevention
Last updated May 04, 2026 16:22 UTC
-
New triple therapy aims to shrink stomach tumors in First-Line trial
Disease control Not yet recruitingThis study is a domestic, multicenter, single-arm clinical trial designed to evaluate the efficacy and safety of heterogeneous radiotherapy (high and low dose) sequenced with iparomlimab and tuvonralimab plus SOX as a first-line treatment for unresectable locally advanced or meta…
Phase: PHASE4 • Sponsor: Huazhong University of Science and Technology • Aim: Disease control
Last updated May 05, 2026 11:52 UTC
-
Could a different chemo drug be better for black caribbean women with breast cancer?
Disease control Not yet recruitingThe goal of this clinical trial is to learn if Gemcitabine, a chemotherapy drug that is usually used to treat breast cancer after other treatments have failed, is better at treating triple negative breast cancer in Black Caribbean women than Paclitaxel, one of the chemotherapy dr…
Phase: PHASE2 • Sponsor: AntiCancer Research Jamaica • Aim: Disease control
Last updated May 04, 2026 16:32 UTC
-
New combo attack on breast cancer brain tumors shows promise in early trial
Disease control Not yet recruitingThis is a prospective, open-label, exploratory clinical trial designed to evaluate the efficacy and safety of brain radiotherapy combined with dalpiciclib and endocrine therapy in HR-positive/HER2-negative advanced breast cancer patients with brain metastases. A total of 46 patie…
Phase: PHASE2 • Sponsor: Nanfang Hospital, Southern Medical University • Aim: Disease control
Last updated May 06, 2026 16:13 UTC
-
New hope for worsening stroke: minimally invasive procedure under trial
Disease control Not yet recruitingThis multicenter, prospective, open-label randomized controlled trial with blinded assessment was designed to assess the efficacy and safety of endovascular treatment for progressive stroke due to vertebrobasilar artery occlusion.
Phase: NA • Sponsor: Feng Gao • Aim: Disease control
Last updated May 06, 2026 16:13 UTC